ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

PU

Peking University First Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Peking University First Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its work focuses on urinary cancers and treatment-related effects. It examines bladder cancer treatment with disitamab vedotin and radiotherapy, kidney cancer treatment in specific patient groups, and blood-related and clotting events associated with immune checkpoint inhibitors.

OrganizationESMO 2026 Attendance
PU
Peking University First Hospital
Beijing, China
Cancer centre & hospital
Teaching hospital of Peking University in Beijing, China.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Sat Oct 24
12:00–12:45
Clinically relevant hematologic and thrombotic adverse event reporting associated with immune checkpoint inhibitors
Saturday Poster Display session 6
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Peking University First Hospital

Tell us what you sell and we’ll find the people at Peking University First Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction